Search Results - "Moutzouri, E"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline by Bekkering, G E, Agoritsas, T, Lytvyn, L, Heen, A F, Feller, M, Moutzouri, E, Abdulazeem, H, Aertgeerts, B, Beecher, D, Brito, J P, Farhoumand, P D, Singh Ospina, N, Rodondi, N, van Driel, M, Wallace, E, Snel, M, Okwen, P M, Siemieniuk, R, Vandvik, P O, Kuijpers, T, Vermandere, M

    Published in BMJ (Online) (14-05-2019)
    “…AbstractClinical questionWhat are the benefits and harms of thyroid hormones for adults with subclinical hypothyroidism (SCH)? This guideline was triggered by…”
    Get full text
    Journal Article
  2. 2

    Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance by Moutzouri, E, Liberopoulos, E, Mikhailidis, D P, Kostapanos, M S, Kei, A A, Milionis, H, Elisaf, M

    “…Statin treatment may be associated with adverse effects on glucose metabolism. Whether this is a class effect is not known. In contrast, ezetimibe monotherapy…”
    Get more information
    Journal Article
  3. 3

    The effect of levothyroxine therapy on depressive symptoms in adults with subclinical hypothyroidism by Wildisen, L, Del Giovane, C, Feller, M, Moutzouri, E, Mooijaart, S, Poortvliet, R, Du Puy, R, Peeters, R, Gussekloo, J, Rodondi, N

    Published in European journal of public health (01-09-2020)
    “…Abstract Background Levothyroxine is one of the most commonly prescribed drugs. A common reason for levothyroxine treatment on patients with subclinical…”
    Get full text
    Journal Article
  4. 4

    483Blood pressure and white matter lesions in patients with atrial fibrillation by Aeschbacher, S, Blum, S, Meyer-Zurn, C, Vischer, A S, Meyre, P, Rodondi, N, Beer, J H, Moschovitis, G, Moutzouri, E, Sticherling, C M, Wurfel, J, Bonati, L H, Osswald, S, Conen, D, Kuhne, M

    Published in European heart journal (01-10-2019)
    “…Abstract Background Hypertension (HTN) is one of the most common cardiovascular risk factors in patients with atrial fibrillation (AF). As a potential risk…”
    Get full text
    Journal Article
  5. 5

    P755The impact of levothyroxine on cardiac function in older adults with subclinical hypothyroidism: a randomized clinical trial by Gencer, B, Moutzouri, E, Blum, M R, Feller, M, Collet, T H, Buffle, E, Monney, P, Gabus, V, Muller, H, Kearney, P, Gussekloo, J, Westendorp, R, Scott, D J, Bauer, D C, Rodondi, N

    Published in European heart journal (01-10-2019)
    “…Abstract Importance Subclinical hypothyroidism has been associated with heart failure, but no conclusive clinical trial assessed whether treating subclinical…”
    Get full text
    Journal Article
  6. 6

    Are Patients with Subclinical Hypothyroidism at Risk of Depressive Symptoms? by Wildisen, L, Moutzouri, E, Beglinger, S, Syrogiannouli, L, Klöppel, S, Aujesky, D, Rodondi, N, Giovane, C Del, Feller, M

    Published in European journal of public health (01-11-2019)
    “…Abstract Introduction Subclinical hypothyroidism (SHypo) may be associated with negative health outcomes including depressive symptoms. However, the evidence…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertension by Moutzouri, E, Florentin, M, Elisaf, M S, Mikhailidis, D P, Liberopoulos, E N

    Published in Current vascular pharmacology (01-05-2010)
    “…Arterial hypertension is an important risk factor for the development and progression of cardiovascular disease (CVD). The renin angiotensin aldosterone system…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11